Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 August 2024 | Story Precious Shamase | Photo Yonela Vimba
commuter lounge Qwaqwa Campus
The new commuter lounge is designed to provide off-campus students with a comfortable and conducive environment for studying, socialising, and relaxation.

The University of the Free State (UFS) Qwaqwa Campus recently celebrated a significant milestone with the preliminary opening of its new commuter lounge. This dedicated space is designed to provide off-campus students with a comfortable and conducive environment for study, socialising, and relaxation.

A diverse crowd gathered to witness the historic event, including university staff and students from the off-campus community.

In his opening remarks, Vice-Principal: Support Services, Teboho Manchu, expressed his enthusiasm for the project. He highlighted the challenges previously faced by off-campus students who lacked adequate study spaces on campus. The new commuter lounge addresses this issue by offering a welcoming environment where students can connect, collaborate, and engage in intellectual discourse.

Quintin Koetaan, Senior Director: Housing and Residence Affairs, shared insights into the journey of bringing the lounge to fruition. He emphasised the collaborative efforts of various stakeholders and expressed gratitude to Coke for its generous sponsorship through the Alumni Office. The lounge also features a laundry facility, a valuable addition for students residing off campus. “Sitting here today really gives me goosebumps, because it is a dream come true for quite a number of people. This student lounge reflects an identity of what it is to be a Kovsie. It reflects us as the university, which is underpinned by the principles of diversity and accessibility. We want to give every one of our students access to a facility they can feel proud of, a facility where intellectual engagement can happen outside of class. This is a dream in terms of Vision 130, which demands of us to create these kinds of spaces that allow for positive interaction to encourage academic success,” expounded Koetaan.

A member of the Student Representative Council (SRC), Potela Zimvo, expressed the SRC’s appreciation for the new facility. He emphasised that the commuter lounge symbolises the university's commitment to inclusivity and support for all students, regardless of their residence status. The lounge is expected to foster a strong sense of community among commuter students and provide a much-needed space for social interaction and academic engagement. “To the university and campus management, thank you for recognising this initiative and providing the necessary resources. We hope that this place will become a central hub for our commuter students and that it will establish a sense of belonging for them. We appreciate the fact that this commuter lounge is equipped with laundry facilities, which will be helpful to our commuter students amid the water and electricity crisis that the Qwaqwa community faces,” said Zimvo.

The official opening ceremony of the commuter lounge is scheduled for later in the year, when it will be officially opened by the Vice-Chancellor and Principal of the University of the Free State, Prof Francis Petersen. However, the university has decided to make the facility available to students immediately to allow them to benefit from the amenities.

This new commuter lounge is a testament to the university's dedication to creating an inclusive and supportive campus environment for all students. It is a space where students can thrive academically and socially, contributing to their overall university experience.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept